RxDoctor Payments Data

Michael Pitman, MD

Otolaryngology · New York, NYNPI 1184683476

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $16,764 of the $17,006 with a category attached, or 98.6%. 6 manufacturers reported payments, led by Cook Incorporated at 48.9% of the total. Reporting peaked in 2020 at $10,018 and has fallen 99.6% since, to $43 in 2025. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,006in general payments, 2019–2025

Across 15 payments — averaging $1133.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$8K
  • Ambu A/s$5K
  • Pentax Of America, Inc.$3K
  • Intersect ENT, Inc.$149
  • Cook Medical LLC$49
  • Regeneron Healthcare Solutions, Inc.$43

What the payments were for

  • Consulting fees$16,76499%
  • Food & beverage$2421%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,006 in reported general payments places this provider in the 90th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$263,511
Medicare patients
322
Services billed
5,988

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine56$1,038
Fluticasone Propionate89$904
Pilocarpine Hcl27$884
Azelastine Hcl22$788
Gabapentin51$680
Ipratropium Bromide17$626
Omeprazole41$334
Amitriptyline Hcl13$206
Chlorhexidine Gluconate16$122
Tramadol Hcl22$120
Methylprednisolone18$105

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →